The telemedicine market in the Asia Pacific is estimated to grow from USD 8.51 billion in 2019 to USD 22.45 billion in 2024, with a compound annual growth rate (CAGR) of 21.40 % over the next five years. Though it is a small part of the
The rise in average age has resulted in elderly patients who need maximum healthcare; this is increasing the overall healthcare cost. The total number of healthcare professionals is not enough to meet the needs of the rising global population. With healthcare specialists spread across the globe, the
Increasing population, a growing number of chronic diseases, a lack of strict guidelines for the practice and improving access to healthcare services are the primary reasons for telemedicine growth in the Asia Pacific region. The shortage of doctors in rural areas is a key opportunity for the growth of this market in this region. limited reimbursement facilities and a lack of consumer awareness hinder the growth of the telemedicine market in these countries.
Medical consultation services will be the regularly used form of telemedicine by doctors for increasing the outreach of their medical advice. The telemonitoring segment will also enjoy an upward shift owing to the increasing diabetic and disabled population.
This research report segmented and sub-segmented into the following categories:
Regionally, the Increasing population and rising incidence of chronic diseases will drive the market especially in India and China. Japan is one of the few countries in the Asia Pacific region providing universal healthcare insurance for all its citizens. Japan Medical Association has made various efforts to support physicians in Japan to ensure the provision of quality healthcare by offering insurance coverage for telehealth services under the universal healthcare insurance system.
Telemedicine players are focused on improving their technology offerings in terms of hardware, network, and software (i.e., enabling technologies). Healthcare companies are estimating the return on investment (ROI) and clinical outcomes of telemedicine technology. Tier I players are estimating opportunities in telemedicine in the form of consolidation. Insurance companies are taking a realistic look at the ability of telemedicine to support e-healthcare and considerably improve the bottom line.
Most promising companies in the Asia Pacific telemedicine market are:
Other important players in the Asia Pacific telemedicine market are
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 By Type
5.1.1 By Technology
5.1.1.1 Hardware
5.1.1.2 Software
5.1.1.3 Telecommunications
5.1.2 By Service
5.1.2.1 Tele-Monitoring
5.1.2.2 Store-and-Forward
5.1.2.3 Real-Time Interactive
5.3 By Applications
5.3.1 Tele-Cardiology
5.3.2 Tele-Radiology
5.3.3 Tele-Pathology
5.3.4 Tele-Dermatology
5.3.5 Tele-Neurology
5.3.6 Emergency Care
5.3.7 Home Health
5.3.8 Others
5.4 By Delivery Mode
5.4.1 Web-based
5.4.2 Cloud-based
5.4.3 Others
5.5 By End User
5.5.1 Tele-Hospitals
5.5.2 Tele-Homes
5.5.3 Others
6.1 Introduction
6.2 China
6.3 India
6.4 Japan
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 AMD Telemedicine
8.3 CISCO Systems, Inc.
8.4 Medtronic, Inc.
8.5 Honeywell Lifesciences
8.6 Aerotel Medical Systems
8.7 Philips healthcare
8.8 McKesson Corp
8.9 Cerner Corporation
8.10 CardioComm
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
Related Reports
Aug 2019
Download Sample
